Gabapentin Treatment of Cannabis Dependence

Completed · Phase 2 · Has a placebo group

Conditions studied: Cannabis Dependence, Cannabis Withdrawal, Cognitive Deficits

In brief

This is a clinical study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.

Key facts

Study ID
NCT00974376
Run by
The Scripps Research Institute
People needed
150
Starts
2009-11-04
Expected to finish
2016-05-19
Last updated by the study team
2017-06-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.